Results 131 to 140 of about 4,091 (198)

CRISPR and the Future of Cardiac Disease Therapy: A New Genetic Frontier. [PDF]

Int J Mol Sci
Sterckel S, Chávez Martínez IL, Schwach V.   +2 more
europepmc   +1 more source

[Correlation of Serum Neuron-Specific Enolase, Angiopoietin-1, and Angiopoietin-Like Protein-3 With Disease Severity and Their Prognostic Value in Patients With Cerebral Infarction]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Liu J, Gao H, Liu Y.
europepmc   +1 more source

Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study. [PDF]

J Atheroscler Thromb
Hirano T, Hayashi T, Sugita H, Tamasawa A, Ohara M, Terasaki M, Ito Y, Yamagishi SI, Mori Y.   +8 more
europepmc   +1 more source

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies. [PDF]

Curr Cardiol Rep
Alam U, Mathai SV, Filtz A, Kuno T, Badimon JJ, Sniderman AD, Virani SS, Toth PP, Shapiro MD, Lavie CJ, Bhatt DL, Slipczuk L.   +11 more
europepmc   +1 more source

Multi-omics data integration from patients with carotid stenosis illuminates key molecular signatures of atherosclerotic instability. [PDF]

Genome Med
Das V, Narayanan S, Zhang X, Bergman O, Djordjevic D, Kronqvist M, Chemaly M, Karadimou G, Sundman S, Prasad I, Buckler AJ, Knape KC, Michaelsen NB, Hedin U, Matic L.   +14 more
europepmc   +1 more source

Olezarsen and Beyond: Emerging Targeted Treatments for Familial Chylomicronemia Syndrome and Related Triglyceride Disorders. [PDF]

J Lipid Atheroscler
N M, C B K, D R S.
europepmc   +1 more source

New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9. [PDF]

Eur Heart J Suppl
Arnaboldi L, Tang Z, Ferri N, Corsini A.
europepmc   +1 more source

Hepatic targeting in ASCVD: integrating lipid lowering and inflammation modulation from statins to gene editing. [PDF]

J Transl Med
Xiao Q, Wang M, Wang S, Wang L, Ding H.
europepmc   +1 more source

Hypertriglyceridemia in chronic kidney disease: pathophysiological mechanisms, cardiovascular risk, and emerging therapeutics. [PDF]

Lipids Health Dis
Li D, Liu Z, Jiang H.
europepmc   +1 more source

Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

J Clin Endocrinol Metab
Gobeil É, Bourgault J, Gagnon E, Samson N, Ruel LJ, Côté V, Mitchell PL, Gotti C, Roux-Dalvai F, Droit A, Bossé Y, Mathieu P, Lajeunesse-Trempe F, Vohl MC, Caron A, Tchernof A, Thériault S, Laplante M, Arsenault BJ.   +18 more
europepmc   +1 more source